{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:19:30Z","timestamp":1760235570321,"version":"build-2065373602"},"reference-count":22,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Peritoneal carcinomatosis frequently occurs in advanced gastrointestinal and gynecological cancers. As factors such as poor drug uptake and distribution cause chemotherapy to be less effective, alternative therapies have been explored. Introduced in 2013, PIPAC (pressurized intraperitoneal aerosol chemotherapy) uses aerosolized chemotherapeutics sprayed into the patient\u2019s peritoneal cavity using a laparoscopic approach. Despite the literature showing encouraging data regarding the tolerability and efficacy of PIPAC, there is a lack of articles on the role that imaging plays in selecting patients suitable for PIPAC. The aim of this study is to combine literature-based evidence and clinical experience to provide information able to support training radiologists, as well as experienced radiologists interested in innovative therapies.<\/jats:p>","DOI":"10.3390\/life11090941","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T12:20:37Z","timestamp":1631190037000},"page":"941","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiologist Checklist for Selecting Patients to Undergo PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy)"],"prefix":"10.3390","volume":"11","author":[{"given":"Elena","family":"Rodolfino","sequence":"first","affiliation":[{"name":"Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margo\u2019","family":"Di Marco","sequence":"additional","affiliation":[{"name":"Section of Radiology, Department of Radiological and Hematological Scienses, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Ilot","sequence":"additional","affiliation":[{"name":"Section of Radiology, Department of Radiological and Hematological Scienses, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2791-481X","authenticated-orcid":false,"given":"Roberto","family":"Iezzi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"},{"name":"Section of Radiology, Department of Radiological and Hematological Scienses, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Gui","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9926-760X","authenticated-orcid":false,"given":"Giacomo","family":"Avesani","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Panico","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Strippoli","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Di Giorgio","sequence":"additional","affiliation":[{"name":"Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Pacelli","sequence":"additional","affiliation":[{"name":"Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Manfredi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, 00168 Rome, Italy"},{"name":"Section of Radiology, Department of Radiological and Hematological Scienses, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Nadiradze, G., Horvath, P., Sautkin, Y., Archid, R., Weinreich, F.-J., K\u00f6nigsrainer, A., and Reymond, M.A. (2019). Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Cancers, 12.","DOI":"10.3390\/cancers12010034"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2743985","DOI":"10.1155\/2018\/2743985","article-title":"Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study","volume":"2018","author":"Kurtz","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: Rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_4","first-page":"385","article-title":"From palliation to cure: PIPAC for peritoneal malignancies","volume":"110","author":"Abatini","year":"2019","journal-title":"Minerva Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"De Simone, M., Vaira, M., Argenziano, M., Berchialla, P., Pisacane, A., Cinquegrana, A., Cavalli, R., Borsano, A., and Robella, M. (2020). Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial. Biomedicines, 8.","DOI":"10.3390\/biomedicines8050102"},{"key":"ref_6","first-page":"1758835920940887","article-title":"Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma","volume":"12","author":"Sgarbura","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s13193-016-0539-8","article-title":"Role of Imaging in Peritoneal Surface Malignancies","volume":"7","author":"Krishnamurthy","year":"2016","journal-title":"Indian J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jviscsurg.2018.01.002","article-title":"Preoperative assessment of peritoneal carcinomatosis of colorectal origin","volume":"155","author":"Dohan","year":"2018","journal-title":"J. Visc. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s13193-016-0518-0","article-title":"Preoperative Assessment of Cancer Patients with Peritoneal Metastases for Complete Cytoreduction","volume":"7","author":"Sugarbaker","year":"2016","journal-title":"Indian J. Surg. Oncol."},{"key":"ref_10","first-page":"58","article-title":"Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy","volume":"7","author":"Low","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.21037\/gs-2019-ursoc-12","article-title":"Pressurized intraperitoneal aerosol chemotherapy for recurrent ovarian, fallopian or primary peritoneal cancer with peritoneal carcinomatosis: A narrative review","volume":"10","author":"Oh","year":"2021","journal-title":"Gland. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.amjsurg.2013.12.024","article-title":"Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis","volume":"207","author":"Rivard","year":"2014","journal-title":"Am. J. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1245\/s10434-010-1492-3","article-title":"Determining the Association Between Preoperative Computed Tomography Findings and Postoperative Outcomes After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei","volume":"18","author":"Chua","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40644-018-0187-z","article-title":"Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases","volume":"19","author":"Dresen","year":"2019","journal-title":"Cancer Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1245\/s10434-014-4041-7","article-title":"Comparison of MRI and CT for Predicting the Peritoneal Cancer Index (PCI) Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures","volume":"22","author":"Low","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1148\/rg.326125511","article-title":"Ovarian Carcinomatosis: How the Radiologist Can Help Plan the Surgical Approach","volume":"32","author":"Nougaret","year":"2012","journal-title":"Radiography"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"20190004","DOI":"10.1515\/pp-2019-0004","article-title":"Staging laparoscopy and Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for peritoneal metastasis: Safe access to the abdomen","volume":"4","author":"Glatz","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1463-1318.2007.01358.x","article-title":"Consequences and complications of peritoneal adhesions","volume":"9","year":"2007","journal-title":"Colorectal. Dis."},{"key":"ref_19","first-page":"6852749","article-title":"Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study","volume":"2017","author":"Farinha","year":"2017","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.suronc.2020.05.006","article-title":"Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis","volume":"34","author":"Schena","year":"2020","journal-title":"Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11605-018-3916-5","article-title":"How to Perform Safe and Technically Optimized Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Experience after a Consecutive Series of 1200 Procedures","volume":"22","author":"Tempfer","year":"2018","journal-title":"J. Gastrointest. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","article-title":"Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: Proof of concept","volume":"26","author":"Solass","year":"2012","journal-title":"Surg. Endosc."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/11\/9\/941\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:59:58Z","timestamp":1760165998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/11\/9\/941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["life11090941"],"URL":"https:\/\/doi.org\/10.3390\/life11090941","relation":{},"ISSN":["2075-1729"],"issn-type":[{"type":"electronic","value":"2075-1729"}],"subject":[],"published":{"date-parts":[[2021,9,9]]}}}